Virios Therapeutics Llc
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,069 | 22 | -1,138 | -1,274 |
EBIT | -1,069 | -1,291 | -2,276 | -2,548 |
Net Income | -1,049 | -1,291 | -1,103 | -1,235 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -811 | -937 | -1,469 | -960 |
Cash | 3,020 | 2,379 | 3,316 | 4,786 |
Basic Shares | 22,900 | 19,257 | 19,257 | 19,093 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | 150 | -12,315 | -15,640 | -10,005 |
EBIT | -5,296 | -12,315 | -15,640 | -10,005 |
Net Income | -5,296 | -12,180 | -15,960 | -10,346 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,870 | -11,467 | -15,689 | -3,895 |
Cash | 3,316 | 7,030 | 14,008 | 29,795 |
Basic Shares | 18,776 | 11,070 | 8,329 | 8,305 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.05 |
2024-03-31 | -$0.07 |
2023-12-31 | -$0.06 |
2023-09-30 | -$0.06 |
